Characterization of neuropathic component of back pain in patients with osteoporotic vertebral fractures.
Osteoporosis
back pain
chronic pain
neuropathic pain
vertebral fractures
Journal
NeuroRehabilitation
ISSN: 1878-6448
Titre abrégé: NeuroRehabilitation
Pays: Netherlands
ID NLM: 9113791
Informations de publication
Date de publication:
2022
2022
Historique:
pubmed:
24
5
2022
medline:
5
10
2022
entrez:
23
5
2022
Statut:
ppublish
Résumé
Osteoporotic vertebral fractures (OVFs) are often followed by chronic back pain which may have a nociceptive, neuropathic, or mixed component. However, literature on this topic is lacking. The objective of this cross-sectional study is to characterize the neuropathic component of chronic back pain in patients with OVFs. Spine fractures were detected by morphometric examination. Pain severity and its impact on activities of daily living (ADL) were evaluated through the Brief Pain Inventory (BPI). Neuropathic pain was investigated through the Italian versions of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale (LANSS) and the painDETECT questionnaire (PD-Q). We included 72 patients, mainly women (88.8%), with mean age of 69.2 years. The 70.8% of patients had multiple OVFs, of which 47% located at the thoracic spine, 43.1% at the thoracic and at lumbar spine, and 9.8% at the lumbar spine. The BPI showed moderate back pain in 23.6% of cases and severe in 8.3% of cases, with high interference with ADL in 38.9% of patients. The PD-Q revealed the presence of neuropathic pain in 5.5% of cases, while the LANSS in 23.6% of cases. In our study, the prevalence of neuropathic component of chronic back pain ranged from 5.5% to 23.6%, according to PD-Q and LANSS respectively, in patients with OVFs. Further studies should investigate if the characterization of chronic back pain might contribute to appropriateness of interventions for this population.
Sections du résumé
BACKGROUND
BACKGROUND
Osteoporotic vertebral fractures (OVFs) are often followed by chronic back pain which may have a nociceptive, neuropathic, or mixed component. However, literature on this topic is lacking.
OBJECTIVE
OBJECTIVE
The objective of this cross-sectional study is to characterize the neuropathic component of chronic back pain in patients with OVFs.
METHODS
METHODS
Spine fractures were detected by morphometric examination. Pain severity and its impact on activities of daily living (ADL) were evaluated through the Brief Pain Inventory (BPI). Neuropathic pain was investigated through the Italian versions of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale (LANSS) and the painDETECT questionnaire (PD-Q).
RESULTS
RESULTS
We included 72 patients, mainly women (88.8%), with mean age of 69.2 years. The 70.8% of patients had multiple OVFs, of which 47% located at the thoracic spine, 43.1% at the thoracic and at lumbar spine, and 9.8% at the lumbar spine. The BPI showed moderate back pain in 23.6% of cases and severe in 8.3% of cases, with high interference with ADL in 38.9% of patients. The PD-Q revealed the presence of neuropathic pain in 5.5% of cases, while the LANSS in 23.6% of cases.
CONCLUSIONS
CONCLUSIONS
In our study, the prevalence of neuropathic component of chronic back pain ranged from 5.5% to 23.6%, according to PD-Q and LANSS respectively, in patients with OVFs. Further studies should investigate if the characterization of chronic back pain might contribute to appropriateness of interventions for this population.
Identifiants
pubmed: 35599506
pii: NRE220040
doi: 10.3233/NRE-220040
pmc: PMC9535576
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
325-331Références
Aging Clin Exp Res. 2015 Oct;27 Suppl 1:S3-9
pubmed: 26210371
J Spinal Disord. 1998 Dec;11(6):526-31
pubmed: 9884299
Spine (Phila Pa 1976). 2016 Aug 1;41(15):1224-1231
pubmed: 26967122
Clin Cases Miner Bone Metab. 2014 Sep;11(3):169-72
pubmed: 25568647
J Bone Miner Res. 1993 Sep;8(9):1137-48
pubmed: 8237484
JAMA. 2001 Jan 17;285(3):320-3
pubmed: 11176842
Best Pract Res Clin Rheumatol. 2013 Dec;27(6):743-55
pubmed: 24836333
J Korean Neurosurg Soc. 2015 Jan;57(1):32-5
pubmed: 25674341
Arthritis Res Ther. 2010;12(6):R226
pubmed: 21190571
J Palliat Med. 2007 Dec;10(6):1338-46
pubmed: 18095813
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
J Orthop Sci. 2017 Jul;22(4):613-617
pubmed: 28284540
Spine J. 2007 Jul-Aug;7(4):428-36
pubmed: 17630141
Osteoporos Int. 2005 Dec;16(12):1823-6
pubmed: 16032373
Neurosciences (Riyadh). 2018 Jan;23(1):23-28
pubmed: 29455217
Bone. 2006 Nov;39(5):1107-1115
pubmed: 16769263
Curr Med Res Opin. 2019 Jan;35(1):151-155
pubmed: 30406685
J Bone Miner Res. 2002 Nov;17(11):2038-47
pubmed: 12412812
Eur J Pain. 2016 Jul;20(6):861-73
pubmed: 26935254
Spine (Phila Pa 1976). 2003 Dec 1;28(23):2570-6
pubmed: 14652473
Osteoporos Int. 2008 Jul;19(7):895-903
pubmed: 18071648
Arthritis Care Res (Hoboken). 2015 Apr;67(4):519-28
pubmed: 25155472
Ann Acad Med Singap. 1994 Mar;23(2):129-38
pubmed: 8080219
Radiol Clin North Am. 2010 May;48(3):561-75
pubmed: 20609892
J Steroid Biochem Mol Biol. 2014 Jul;142:155-70
pubmed: 24176761
J Pain Res. 2016 Apr 01;9:177-86
pubmed: 27099529
Pain. 1996 Apr;65(1):87-92
pubmed: 8826494
Spine (Phila Pa 1976). 2013 Nov 15;38(24):2085-91
pubmed: 24225423
Radiology. 2013 Nov;269(2):525-33
pubmed: 23801776
J Bone Miner Res. 1999 Jun;14(6):960-8
pubmed: 10352105
Spine (Phila Pa 1976). 2010 Oct 15;35(22):1974-82
pubmed: 20959778
Ann Oncol. 2008 Dec;19(12):1985-91
pubmed: 18632721
Pain Res Manag. 2021 Apr 28;2021:6623651
pubmed: 34012496